Orchestra BioMed Holdings (OBIO) Financial Statements
Price: $2.58
Market Cap: $98.85M
Avg Volume: 298.35K
Market Cap: $98.85M
Avg Volume: 298.35K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Orchestra BioMed Holdings.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $2.64M | $2.76M | $3.53M | $-782.00K | $5.70M |
| Cost of Revenue | $204.00K | $186.00K | $322.00K | $199.00K | $145.00K |
| Gross Profit | $2.43M | $2.57M | $3.21M | $-981.00K | $5.56M |
| Gross Profit Ratio | 92.27% | 93.26% | 90.89% | 125.45% | 97.46% |
| Research and Development Expenses | $42.80M | $33.82M | $21.95M | $12.89M | $13.48M |
| General and Administrative Expenses | $- | $- | $- | $- | $- |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $23.93M | $20.26M | $13.92M | $7.93M | $10.83M |
| Other Expenses | $- | $- | $- | $- | $- |
| Operating Expenses | $66.73M | $54.08M | $35.87M | $20.82M | $24.31M |
| Cost and Expenses | $66.94M | $54.27M | $36.19M | $21.02M | $24.45M |
| Interest Income | $3.36M | $3.85M | $50.00K | $927.00K | $331.00K |
| Interest Expense | $- | $- | $- | $927.00K | $- |
| Depreciation and Amortization | $- | $287.00K | $222.00K | $181.00K | $137.00K |
| EBITDA | $-64.30M | $-51.22M | $-32.44M | $-21.62M | $-18.61M |
| EBITDA Ratio | -2437.49% | -1855.76% | -918.06% | 2764.45% | -326.41% |
| Operating Income | $-64.30M | $-51.51M | $-32.66M | $-21.80M | $-18.75M |
| Operating Income Ratio | -2437.49% | -1866.16% | -924.34% | 2787.60% | -328.81% |
| Total Other Income Expenses Net | $3.28M | $2.39M | $-951.00K | $-1.22M | $-2.60M |
| Income Before Tax | $-61.02M | $-49.12M | $-33.61M | $-23.01M | $-21.36M |
| Income Before Tax Ratio | -2313.27% | -1779.71% | -951.26% | 2942.97% | -374.45% |
| Income Tax Expense | $- | $- | $-222.00K | $927.00K | $2.60M |
| Net Income | $-61.02M | $-49.12M | $-33.61M | $-23.01M | $-21.36M |
| Net Income Ratio | -2313.27% | -1779.71% | -951.26% | 2942.97% | -374.45% |
| EPS | $-1.66 | $-1.48 | $-2.24 | $-1.13 | $-1.04 |
| EPS Diluted | $-1.66 | $-1.48 | $-2.24 | $-1.13 | $-1.04 |
| Weighted Average Shares Outstanding | 36.82M | 33.23M | 14.99M | 20.45M | 20.45M |
| Weighted Average Shares Outstanding Diluted | 36.82M | 33.23M | 14.99M | 20.45M | 20.45M |
| SEC Filing | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $22.26M | $30.56M | $19.78M | $9.94M | $20.34M |
| Short Term Investments | $44.55M | $57.04M | $64.00M | $958.00K | $15.45M |
| Cash and Short Term Investments | $66.81M | $87.59M | $83.78M | $10.90M | $35.79M |
| Net Receivables | $92.00K | $99.00K | $96.00K | $121.00K | $168.00K |
| Inventory | $173.00K | $146.00K | $276.00K | $68.00K | $69.00K |
| Other Current Assets | $2.09M | $1.27M | $533.00K | $234.00K | $227.00K |
| Total Current Assets | $69.17M | $89.11M | $84.69M | $11.32M | $36.25M |
| Property Plant Equipment Net | $3.49M | $2.83M | $3.68M | $1.12M | $1.03M |
| Goodwill | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- |
| Long Term Investments | $2.50M | $2.50M | $2.50M | $398.00K | $185.00K |
| Tax Assets | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $1.02M | $769.00K | $4.71M | $690.00K | $626.00K |
| Total Non-Current Assets | $7.00M | $6.10M | $10.88M | $2.21M | $1.84M |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $76.17M | $95.21M | $95.57M | $13.53M | $38.09M |
| Account Payables | $5.13M | $2.90M | $3.97M | $2.03M | $1.77M |
| Short Term Debt | $550.00K | $649.00K | $697.00K | $2.00M | $4.00M |
| Tax Payables | $- | $- | $- | $1.00K | $67.00K |
| Deferred Revenue | $4.44M | $2.51M | $6.44M | $5.54M | $5.80M |
| Other Current Liabilities | $6.08M | $5.15M | $7.46M | $8.21M | $8.52M |
| Total Current Liabilities | $16.21M | $11.21M | $18.57M | $12.24M | $14.36M |
| Long Term Debt | $1.69M | $1.04M | $11.17M | $3.67M | $5.46M |
| Deferred Revenue Non-Current | $- | $14.92M | $13.10M | $16.86M | $15.12M |
| Deferred Tax Liabilities Non-Current | $- | $- | $1.68M | $51.45M | $51.45M |
| Other Non-Current Liabilities | $25.32M | $- | $196.00K | $-34.06M | $-36.09M |
| Total Non-Current Liabilities | $27.01M | $15.96M | $24.47M | $72.52M | $72.27M |
| Other Liabilities | $- | $- | $1 | $- | $- |
| Total Liabilities | $43.22M | $27.17M | $43.04M | $84.76M | $86.63M |
| Preferred Stock | $- | $- | $51.45M | $51.45M | $51.45M |
| Common Stock | $4.00K | $4.00K | $2.00K | $160.00M | $160.00M |
| Retained Earnings | $-309.88M | $-248.85M | $-199.73M | $-166.13M | $-143.11M |
| Accumulated Other Comprehensive Income Loss | $52.00K | $-10.00K | $-8.00K | $-211.45M | $-2.00K |
| Other Total Stockholders Equity | $342.78M | $316.90M | $252.27M | $357.80M | $146.02M |
| Total Stockholders Equity | $32.96M | $68.04M | $52.53M | $-71.23M | $-48.54M |
| Total Equity | $32.96M | $68.04M | $52.53M | $-71.23M | $-48.54M |
| Total Liabilities and Stockholders Equity | $76.17M | $95.21M | $95.57M | $13.53M | $38.09M |
| Minority Interest | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $76.17M | $95.21M | $95.57M | $13.53M | $38.09M |
| Total Investments | $47.05M | $59.53M | $66.50M | $1.36M | $15.63M |
| Total Debt | $2.24M | $1.69M | $11.87M | $5.67M | $9.46M |
| Net Debt | $-20.02M | $-28.87M | $-7.91M | $-4.26M | $-10.89M |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $-61.02M | $-49.12M | $-33.61M | $-23.01M | $-21.36M |
| Depreciation and Amortization | $308.00K | $287.00K | $222.00K | $181.00K | $137.00K |
| Deferred Income Tax | $- | $- | $-3.63M | $288.00K | $- |
| Stock Based Compensation | $10.62M | $7.62M | $3.41M | $302.00K | $221.00K |
| Change in Working Capital | $-765.00K | $-3.31M | $-451.00K | $2.60M | $-8.12M |
| Accounts Receivables | $22.00K | $-3.00K | $25.00K | $47.00K | $-79.00K |
| Inventory | $-28.00K | $131.00K | $-208.00K | $1.00K | $-26.00K |
| Accounts Payables | $2.97M | $145.00K | $183.00K | $1.08M | $-2.61M |
| Other Working Capital | $-3.73M | $-3.58M | $-451.00K | $1.47M | $-5.41M |
| Other Non Cash Items | $308.00K | $-1.61M | $4.77M | $217.00K | $2.93M |
| Net Cash Provided by Operating Activities | $-50.56M | $-46.13M | $-29.29M | $-19.43M | $-26.18M |
| Investments in Property Plant and Equipment | $-289.00K | $-78.00K | $-591.00K | $-274.00K | $-539.00K |
| Acquisitions Net | $- | $- | $-29.06M | $-13.29M | $-27.50M |
| Purchases of Investments | $-72.65M | $-142.03M | $-63.53M | $-213.00K | $-15.62M |
| Sales Maturities of Investments | $86.63M | $152.80M | $92.59M | $13.50M | $43.13M |
| Other Investing Activities | $-602.00K | $- | $-63.53M | $13.29M | $27.50M |
| Net Cash Used for Investing Activities | $13.09M | $10.69M | $-64.12M | $13.02M | $26.97M |
| Debt Repayment | $15.00M | $-10.85M | $3.55M | $-4.00M | $10.00M |
| Common Stock Issued | $15.04M | $254.00K | $109.83M | $- | $162.29M |
| Common Stock Repurchased | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- |
| Other Financing Activities | $-864.00K | $57.06M | $-10.13M | $7.00K | $- |
| Net Cash Used Provided by Financing Activities | $29.17M | $46.22M | $103.26M | $-3.99M | $10.00M |
| Effect of Forex Changes on Cash | $- | $- | $11.43M | $- | $- |
| Net Change in Cash | $-8.30M | $10.78M | $18.03M | $-10.40M | $10.78M |
| Cash at End of Period | $22.26M | $30.56M | $19.78M | $9.94M | $20.34M |
| Cash at Beginning of Period | $30.56M | $19.78M | $1.75M | $20.34M | $9.56M |
| Operating Cash Flow | $-50.56M | $-46.13M | $-29.29M | $-19.43M | $-26.18M |
| Capital Expenditure | $-289.00K | $-78.00K | $-591.00K | $-274.00K | $-539.00K |
| Free Cash Flow | $-50.85M | $-46.20M | $-29.88M | $-19.70M | $-26.72M |